These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16450540)

  • 1. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
    East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Fam Pract; 2005 Dec; 22(6):624-30. PubMed ID: 16055474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric homoeopathy in general practice: where, when and why?
    Ekins-Daukes S; Helms PJ; Taylor MW; Simpson CR; McLay JS
    Br J Clin Pharmacol; 2005 Jun; 59(6):743-9. PubMed ID: 15948942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GPs' perceptions of the Institute for Rational Pharmacotherapy].
    Gudex C; Hoffmann M; Brørs O; Dahlqvist R
    Ugeskr Laeger; 2009 Feb; 171(7):522-6. PubMed ID: 19210936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
    Vancelik S; Beyhun NE; Acemoglu H; Calikoglu O
    BMC Public Health; 2007 Jun; 7():122. PubMed ID: 17592644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
    Thomson AN; Craig BJ; Barham PM
    Br J Gen Pract; 1994 May; 44(382):220-3. PubMed ID: 8204336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
    de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP
    BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of informational interventions about cognitive behavioral therapy for chronic fatigue syndrome on GPs referral behavior.
    Scheeres K; Wensing M; Mes C; Bleijenberg G
    Patient Educ Couns; 2007 Sep; 68(1):29-32. PubMed ID: 17521842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulation of pharmaceutical information among general practitioners in the region of Sousse (Tunisia)].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Gaha R; Ghannem H
    Therapie; 2002; 57(3):229-35. PubMed ID: 12422532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The views of Otago urban and rural general practitioners on mental health services.
    Bathgate D; Bermingham B; Curtis D; Romans S
    N Z Med J; 2001 Jun; 114(1134):289-91. PubMed ID: 11480512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General practitioners' attitudes towards psychotic disorders and their treatment in the primary health care system].
    Yildiz M; Emin Onder M; Tural U; Ibrahim Balta H; Koçalim N
    Turk Psikiyatri Derg; 2003; 14(2):106-15. PubMed ID: 12844277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practitioners facing dementia: are they fully prepared?
    Pucci E; Angeleri F; Borsetti G; Brizioli E; Cartechini E; Giuliani G; Solari A
    Neurol Sci; 2004 Feb; 24(6):384-9. PubMed ID: 14767683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to professional guidelines for patients with urinary incontinence by general practitioners: a cross-sectional study.
    Albers-Heitner P; Berghmans B; Nieman F; Lagro-Janssen T; Winkens R
    J Eval Clin Pract; 2008 Oct; 14(5):807-11. PubMed ID: 18462277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitudes and practice of general practitioners towards complementary and alternative medicine in Doha, Qatar.
    Al SI; Ismail MF; Yousuf WA; Salama RE
    East Mediterr Health J; 2010 May; 16(5):522-7. PubMed ID: 20799552
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of pharmaceutical representative visits on GPs' drug preferences.
    Søndergaard J; Vach K; Kragstrup J; Andersen M
    Fam Pract; 2009 Jun; 26(3):204-9. PubMed ID: 19273463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding why GPs see pharmaceutical representatives: a qualitative interview study.
    Prosser H; Walley T
    Br J Gen Pract; 2003 Apr; 53(489):305-11. PubMed ID: 12879831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.